General form of registration statement for all companies including face-amount certificate companies

Consolidated Statement of Operations

v2.4.0.8
Consolidated Statement of Operations (USD $)
 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Revenue:    
Medical devices $ 1,611,709 $ 566,222
Engineering services 1,690,235 2,140,355
Total revenue 3,301,944 2,706,577
Cost of revenue:    
Cost of medical devices 1,460,692 553,429
Cost of engineering services 1,253,942 1,782,848
Total cost of revenue 2,714,634 2,336,277
Gross Profit 587,310 370,300
Operating expenses:    
General and administrative 3,913,047 4,381,067
Research and development 2,677,310 4,304,317
Sales and marketing 4,291,282 5,925,905
Total operating expenses 10,881,639 14,611,289
Loss from operations (10,294,329) (14,240,989)
Other income (expense):    
Interest expense (1,726,455) (736,346)
Interest income 5,225 10,692
Non-cash gain on changes in fair value of warrants 186,075 17,126
Other expense, net (57,890) (92,441)
Total other income (expense), net (1,593,045) (800,969)
Net loss $ (11,887,374) $ (15,041,958)